peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
SPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0016021 (2%),extracellular space (11%);integral component of membrane (2%),GO:0004252 (100%);GO:0046872 (4%),serine-type endopeptidase activity (100%);metal ion binding (4%),GO:0006508 (11%);GO:0007586 (4%),proteolysis (11%);digestion (4%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
LSSPATLDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WNQQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATVLSPR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002634 (100%);IPR036065 (100%),BolA protein (100%);BolA-like superfamily (100%)
VVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0008134 (100%);GO:0043565 (100%),ATP binding (100%);transcription factor binding (100%);sequence-specific DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001789 (100%);IPR002078 (100%);IPR002197 (100%),Signal transduction response regulator, receiver domain (100%);RNA polymerase sigma factor 54 interaction domain (100%);DNA binding HTH domain,  Fis-type (100%)
VATVSPLR,Solirubrobacteraceae,Bacteria,,,,Actinobacteria,,,Thermoleophilia,,,Solirubrobacterales,,,,Solirubrobacteraceae,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC3 transporter permease protein domain (100%);MacB-like periplasmic core domain (100%)
NGQQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.1 (75%);2.7.9.2 (25%),Sarcosine oxidase (75%);Pyruvate, water dikinase (25%),GO:0005737 (60%);GO:0031463 (20%),cytoplasm (60%);Cul3-RING ubiquitin ligase complex (20%),GO:0008115 (60%);GO:0005524 (20%);GO:0008986 (20%),sarcosine oxidase activity (60%);ATP binding (20%);pyruvate, water dikinase activity (20%),GO:0046653 (60%);GO:0006090 (20%);GO:0006094 (20%),tetrahydrofolate metabolic process (60%);pyruvate metabolic process (20%);gluconeogenesis (20%),IPR006222 (50%);IPR006277 (50%);IPR013977 (50%),Aminomethyltransferase, folate-binding domain (50%);Sarcosine oxidase, alpha subunit (50%);Glycine cleavage T-protein, C-terminal barrel domain (50%)
ELYLSWVVEAR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,1.6.2.4 (100%),NADPH--hemoprotein reductase (100%),GO:0016021 (90%);GO:0005789 (76%);GO:0005783 (8%),integral component of membrane (90%);endoplasmic reticulum membrane (76%);endoplasmic reticulum (8%),GO:0010181 (95%);GO:0003958 (88%);GO:0050660 (76%),FMN binding (95%);NADPH-hemoprotein reductase activity (88%);flavin adenine dinucleotide binding (76%),GO:0009725 (5%);GO:0003420 (2%);GO:0007584 (2%),response to hormone (5%);regulation of growth plate cartilage chondrocyte proliferation (2%);response to nutrient (2%),IPR003097 (100%);IPR017938 (100%);IPR023173 (100%),Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding (100%);Riboflavin synthase-like beta-barrel (100%);NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily (100%)
VVTVLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007165 (100%),signal transduction (100%),IPR000157 (100%);IPR035897 (100%),Toll/interleukin-1 receptor homology (TIR) domain (100%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (100%)
VLQGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QEFLNAAK,Phorcysia thermohydrogeniphila,Bacteria,,,,Aquificae,,,Aquificae,,,Desulfurobacteriales,,,,Desulfurobacteriaceae,,,,Phorcysia,,,,Phorcysia thermohydrogeniphila,,,,,,,,,,GO:0009055 (100%);GO:0020037 (100%);GO:0046872 (100%),electron transfer activity (100%);heme binding (100%);metal ion binding (100%),,,IPR009056 (100%),Cytochrome c-like domain (100%)
MLNAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.- (49%);2.2.1.6 (12%);3.4.11.4 (8%),Transferases for other substituted phosphate groups (49%);Acetolactate synthase (12%);Tripeptide aminopeptidase (8%),GO:0016021 (34%);GO:0005886 (22%);GO:0005737 (7%),integral component of membrane (34%);plasma membrane (22%);cytoplasm (7%),GO:0008808 (20%);GO:0005524 (10%);GO:0016491 (6%),cardiolipin synthase activity (20%);ATP binding (10%);oxidoreductase activity (6%),GO:0032049 (20%);GO:0006508 (5%);GO:0032259 (4%),cardiolipin biosynthetic process (20%);proteolysis (5%);methylation (4%),IPR001736 (16%);IPR022924 (16%);IPR025202 (16%),Phospholipase D/Transphosphatidylase (16%);Cardiolipin synthase (16%);Phospholipase D-like domain (16%)
MVLNAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTVNLNSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR013783 (100%);IPR036179 (100%),Immunoglobulin-like fold (100%);Immunoglobulin-like domain superfamily (100%)
YLYEALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.19 (33%);3.5.2.6 (33%);3.5.4.4 (33%),4-methylaminobutanoate oxidase (formaldehyde-forming) (33%);Beta-lactamase (33%);Adenosine deaminase (33%),GO:0016021 (7%);GO:0005886 (4%);GO:0031514 (4%),integral component of membrane (7%);plasma membrane (4%);motile cilium (4%),GO:0016491 (37%);GO:0001681 (11%);GO:0004197 (9%),oxidoreductase activity (37%);sialate O-acetylesterase activity (11%);cysteine-type endopeptidase activity (9%),GO:0006979 (2%);GO:0019350 (2%);GO:0031119 (2%),response to oxidative stress (2%);teichoic acid biosynthetic process (2%);tRNA pseudouridine synthesis (2%),IPR002347 (30%);IPR020904 (30%);IPR036291 (30%),Short-chain dehydrogenase/reductase SDR (30%);Short-chain dehydrogenase/reductase, conserved site (30%);NAD(P)-binding domain superfamily (30%)
SSPATLNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLGAYK,Eubacteriales,Bacteria,,,,Firmicutes,,,Clostridia,,,Eubacteriales,,,,,,,,,,,,,,,,,,5.3.1.9 (100%),Glucose-6-phosphate isomerase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004347 (100%),glucose-6-phosphate isomerase activity (100%),GO:0006094 (100%);GO:0006096 (100%),gluconeogenesis (100%);glycolytic process (100%),IPR010551 (100%);IPR011051 (100%);IPR014710 (100%),Glucose-6-phosphate isomerase, prokaryote (100%);RmlC-like cupin domain superfamily (100%);RmlC-like jelly roll fold (100%)
FVNMMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (67%);2.3.1.1 (7%);2.3.1.20 (7%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (67%);Amino-acid N-acetyltransferase (7%);Diacylglycerol O-acyltransferase (7%),GO:0016021 (32%);GO:0005737 (7%);GO:0005886 (7%),integral component of membrane (32%);cytoplasm (7%);plasma membrane (7%),GO:0005524 (39%);GO:0004088 (36%);GO:0016491 (14%),ATP binding (39%);carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity (36%);oxidoreductase activity (14%),GO:0006526 (39%);GO:0006207 (36%);GO:0006541 (36%),arginine biosynthetic process (39%);'de novo' pyrimidine nucleobase biosynthetic process (36%);glutamine metabolic process (36%),IPR002474 (34%);IPR006274 (34%);IPR017926 (34%),Carbamoyl-phosphate synthase small subunit, N-terminal domain (34%);Carbamoyl-phosphate synthase, small subunit (34%);Glutamine amidotransferase (34%)
VGPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0051301 (80%),cell division (80%),IPR001182 (100%),Probable peptidoglycan glycosyltransferase FtsW/RodA (100%)
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (61%);GO:0001533 (33%),keratin filament (100%);plasma membrane (61%);cornified envelope (33%),GO:0046982 (35%);GO:0030246 (33%);GO:0030280 (33%),protein heterodimerization activity (35%);carbohydrate binding (33%);structural constituent of skin epidermis (33%),GO:0051290 (35%);GO:0001867 (33%);GO:0018149 (33%),protein heterotetramerization (35%);complement activation, lectin pathway (33%);peptide cross-linking (33%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
HMFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLGFSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (40%);5.6.2.1 (40%);3.6.4.12 (20%),RNA-directed RNA polymerase (40%);DNA topoisomerase (40%);DNA helicase (20%),,,GO:0003677 (44%);GO:0000155 (33%);GO:0000287 (22%),DNA binding (44%);phosphorelay sensor kinase activity (33%);magnesium ion binding (22%),GO:0006265 (22%);GO:0039694 (22%);GO:0006139 (11%),DNA topological change (22%);viral RNA genome replication (22%);nucleobase-containing compound metabolic process (11%),IPR000253 (33%);IPR003018 (33%);IPR003594 (33%),Forkhead-associated (FHA) domain (33%);GAF domain (33%);Histidine kinase/HSP90-like ATPase (33%)
MLLQLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.12 (22%);2.7.7.85 (9%);2.7.3.9 (9%),Prephenate dehydrogenase (22%);Diadenylate cyclase (9%);Phosphoenolpyruvate--protein phosphotransferase (9%),GO:0016021 (25%);GO:0005737 (18%);GO:0005856 (9%),integral component of membrane (25%);cytoplasm (18%);cytoskeleton (9%),GO:0003677 (17%);GO:0005524 (15%);GO:0003700 (11%),DNA binding (17%);ATP binding (15%);DNA-binding transcription factor activity (11%),GO:0006352 (9%);GO:0006571 (6%);GO:0006281 (4%),DNA-templated transcription, initiation (9%);tyrosine biosynthetic process (6%);DNA repair (4%),IPR036388 (12%);IPR027417 (12%);IPR025254 (10%),Winged helix-like DNA-binding domain superfamily (12%);P-loop containing nucleoside triphosphate hydrolase (12%);Domain of unknown function DUF4201 (10%)
LSLSPAAEPPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYLSWLVDAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QEVHLFDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSLVSPLR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000166 (50%),nucleotide binding (50%),GO:0006633 (50%),fatty acid biosynthetic process (50%),IPR001611 (50%);IPR003231 (50%);IPR003591 (50%),Leucine-rich repeat (50%);Acyl carrier protein (ACP) (50%);Leucine-rich repeat, typical subtype (50%)
HTMSGWTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMMPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMGDDAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMWLSVQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YSMMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMMPLVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EWSSGSGLNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLFLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTTANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTSLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.2 (40%);5.4.99.- (8%);2.7.4.1 (5%),CTP synthase (glutamine hydrolyzing) (40%);Transferring other groups (8%);Polyphosphate kinase (5%),GO:0016021 (16%);GO:0005634 (10%);GO:0005737 (8%),integral component of membrane (16%);nucleus (10%);cytoplasm (8%),GO:0005524 (28%);GO:0003883 (14%);GO:0003691 (8%),ATP binding (28%);CTP synthase activity (14%);double-stranded telomeric DNA binding (8%),GO:0006541 (13%);GO:0044210 (13%);GO:0045893 (8%),glutamine metabolic process (13%);'de novo' CTP biosynthetic process (13%);positive regulation of transcription, DNA-templated (8%),IPR027417 (20%);IPR004468 (12%);IPR017456 (12%),P-loop containing nucleoside triphosphate hydrolase (20%);CTP synthase (12%);CTP synthase, N-terminal (12%)
LEAFFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.20 (28%);3.1.-.- (8%);1.97.1.- (7%),Phenylalanine--tRNA ligase (28%);Acting on ester bonds (8%);Other oxidoreductases (7%),GO:0016021 (17%);GO:0005737 (12%);GO:0005886 (7%),integral component of membrane (17%);cytoplasm (12%);plasma membrane (7%),GO:0003677 (14%);GO:0005524 (14%);GO:0016787 (13%),DNA binding (14%);ATP binding (14%);hydrolase activity (13%),GO:0006541 (8%);GO:0006432 (6%);GO:0055085 (5%),glutamine metabolic process (8%);phenylalanyl-tRNA aminoacylation (6%);transmembrane transport (5%),IPR029058 (12%);IPR017926 (7%);IPR029062 (7%),Alpha/Beta hydrolase fold (12%);Glutamine amidotransferase (7%);Class I glutamine amidotransferase-like (7%)
WYYHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SYYVHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLYVHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FHEVHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPGWLHTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WPLVELLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLEGNEQFLNAAK,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (15%);GO:0005576 (4%);GO:1904724 (4%),extracellular space (15%);extracellular region (4%);tertiary granule lumen (4%),GO:0004252 (100%);GO:0005509 (12%);GO:0008236 (4%),serine-type endopeptidase activity (100%);calcium ion binding (12%);serine-type peptidase activity (4%),GO:0006508 (12%);GO:0031638 (12%);GO:0043542 (12%),proteolysis (12%);zymogen activation (12%);endothelial cell migration (12%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
SLSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (50%);3.5.99.2 (50%),Electron-transferring-flavoprotein dehydrogenase (50%);Aminopyrimidine aminohydrolase (50%),GO:0045095 (92%);GO:0005886 (47%);GO:0001533 (37%),keratin filament (92%);plasma membrane (47%);cornified envelope (37%),GO:0030280 (37%);GO:0046982 (36%);GO:0030246 (35%),structural constituent of skin epidermis (37%);protein heterodimerization activity (36%);carbohydrate binding (35%),GO:0018149 (37%);GO:0051290 (36%);GO:0001867 (35%),peptide cross-linking (37%);protein heterotetramerization (36%);complement activation, lectin pathway (35%),IPR032444 (92%);IPR003054 (91%);IPR039008 (91%),Keratin type II head (92%);Keratin, type II (91%);Intermediate filament, rod domain (91%)
QTPELHTLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FFEEEYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.2.4 (100%),3-hydroxyisobutyryl-CoA hydrolase (100%),GO:0005737 (20%);GO:0005739 (20%);GO:0019773 (20%),cytoplasm (20%);mitochondrion (20%);proteasome core complex, alpha-subunit complex (20%),GO:0003860 (40%);GO:0004298 (20%);GO:0008137 (20%),3-hydroxyisobutyryl-CoA hydrolase activity (40%);threonine-type endopeptidase activity (20%);NADH dehydrogenase (ubiquinone) activity (20%),GO:0001510 (20%);GO:0006511 (20%);GO:0006574 (20%),RNA methylation (20%);ubiquitin-dependent protein catabolic process (20%);valine catabolic process (20%),IPR018376 (40%);IPR029045 (40%);IPR032259 (40%),Enoyl-CoA hydratase/isomerase, conserved site (40%);ClpP/crotonase-like domain superfamily (40%);Enoyl-CoA hydratase/isomerase,  HIBYL-CoA-H type (40%)
SPATLSNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLAAMMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (50%),DNA binding (50%),GO:0000160 (50%);GO:0006355 (50%),phosphorelay signal transduction system (50%);regulation of transcription, DNA-templated (50%),IPR001789 (50%);IPR001867 (50%);IPR011006 (50%),Signal transduction response regulator, receiver domain (50%);OmpR/PhoB-type DNA-binding domain (50%);CheY-like superfamily (50%)
APVLSDCSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APVLSDSSCK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (33%),extracellular space (33%),GO:0004252 (100%);GO:0046872 (17%),serine-type endopeptidase activity (100%);metal ion binding (17%),GO:0006508 (33%);GO:0007586 (17%),proteolysis (33%);digestion (17%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLYELAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.35 (57%);2.5.1.7 (14%);2.7.13.3 (14%),Pyridoxal kinase (57%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (14%);Histidine kinase (14%),GO:0005615 (86%);GO:0005737 (19%);GO:0032991 (9%),extracellular space (86%);cytoplasm (19%);protein-containing complex (9%),GO:0046872 (43%);GO:0005504 (14%);GO:0003677 (9%),metal ion binding (43%);fatty acid binding (14%);DNA binding (9%),GO:0001542 (13%);GO:0042448 (13%);GO:0060395 (13%),ovulation from ovarian follicle (13%);progesterone metabolic process (13%);SMAD protein signal transduction (13%),IPR000264 (90%);IPR014760 (90%);IPR020858 (90%),ALB/AFP/VDB (90%);Serum albumin, N-terminal (90%);Serum albumin-like (90%)
LSSLSGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.5.3 (50%);2.1.1.72 (50%),Aerobic carbon monoxide dehydrogenase (50%);Site-specific DNA-methyltransferase (adenine-specific) (50%),GO:0016021 (27%);GO:0019898 (20%);GO:0005741 (13%),integral component of membrane (27%);extrinsic component of membrane (20%);mitochondrial outer membrane (13%),GO:0003677 (7%);GO:0004527 (7%);GO:0005524 (7%),DNA binding (7%);exonuclease activity (7%);ATP binding (7%),GO:0006914 (20%);GO:0007399 (13%);GO:0007626 (13%),autophagy (20%);nervous system development (13%);locomotory behavior (13%),IPR009543 (28%);IPR015412 (28%);IPR026847 (28%),Vacuolar protein sorting-associated protein 13, SHR-binding domain (28%);Autophagy-related, C-terminal (28%);Vacuolar protein sorting-associated protein 13 (28%)
MVDLAGYLK,archaeon,Archaea,,,,,,,,,,,,,,,,,,,,,,archaeon,,,,,,,,,,,,,,,
YLYGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.2 (26%);3.4.21.89 (13%);3.6.4.12 (5%),Membrane alanyl aminopeptidase (26%);Signal peptidase I (13%);DNA helicase (5%),GO:0016021 (32%);GO:0005886 (8%);GO:0005615 (5%),integral component of membrane (32%);plasma membrane (8%);extracellular space (5%),GO:0005524 (13%);GO:0008270 (10%);GO:0003677 (8%),ATP binding (13%);zinc ion binding (10%);DNA binding (8%),GO:0006956 (6%);GO:0006310 (3%);GO:0006954 (3%),complement activation (6%);DNA recombination (3%);inflammatory response (3%),IPR027417 (10%);IPR013783 (6%);IPR014782 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Immunoglobulin-like fold (6%);Peptidase M1, membrane alanine aminopeptidase (6%)
LLLTWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (62%);2.3.1.37 (12%);2.7.7.7 (5%),RING-type E3 ubiquitin transferase (62%);5-aminolevulinate synthase (12%);DNA-directed DNA polymerase (5%),GO:0016021 (27%);GO:0005829 (18%);GO:1990112 (17%),integral component of membrane (27%);cytosol (18%);RQC complex (17%),GO:0043023 (17%);GO:0061630 (17%);GO:0008270 (15%),ribosomal large subunit binding (17%);ubiquitin protein ligase activity (17%);zinc ion binding (15%),GO:0072344 (17%);GO:1990116 (17%);GO:0005975 (7%),rescue of stalled ribosome (17%);ribosome-associated ubiquitin-dependent protein catabolic process (17%);carbohydrate metabolic process (7%),IPR016024 (15%);IPR039795 (15%);IPR013083 (12%),Armadillo-type fold (15%);E3 ubiquitin-protein ligase listerin (15%);Zinc finger, RING/FYVE/PHD-type (12%)
AFMCPDGAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVSLLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.3 (100%),Glutamate racemase (100%),GO:0005886 (20%);GO:0016021 (20%),plasma membrane (20%);integral component of membrane (20%),GO:0016832 (40%);GO:0008881 (20%);GO:0016810 (20%),aldehyde-lyase activity (40%);glutamate racemase activity (20%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (20%),GO:0005975 (40%);GO:0008360 (20%);GO:0009252 (20%),carbohydrate metabolic process (40%);regulation of cell shape (20%);peptidoglycan biosynthetic process (20%),IPR005475 (33%);IPR005593 (33%);IPR009014 (33%),Transketolase-like, pyrimidine-binding domain (33%);Xylulose 5-phosphate/Fructose 6-phosphate phosphoketolase (33%);Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II (33%)
LCEPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.16 (32%);3.4.22.28 (7%);7.2.2.6 (7%),GTP cyclohydrolase I (32%);Picornain 3C (7%);P-type K(+) transporter (7%),GO:0000786 (45%);GO:0005634 (9%);GO:0016021 (8%),nucleosome (45%);nucleus (9%);integral component of membrane (8%),GO:0003677 (52%);GO:0003682 (40%);GO:0005524 (9%),DNA binding (52%);chromatin binding (40%);ATP binding (9%),GO:0006355 (47%);GO:0006334 (45%);GO:0070828 (45%),regulation of transcription, DNA-templated (47%);nucleosome assembly (45%);heterochromatin organization (45%),IPR036388 (44%);IPR005818 (43%);IPR033061 (43%),Winged helix-like DNA-binding domain superfamily (44%);Linker histone H1/H5, domain H15 (43%);Heterochromatin protein 1-binding protein 3 (43%)
ELWYSTAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YTDLVTVVSLVGQPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLAER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.- (12%);2.5.1.61 (5%);1.2.1.11 (5%),With NAD(+) or NADP(+) as acceptor (12%);Hydroxymethylbilane synthase (5%);Aspartate-semialdehyde dehydrogenase (5%),GO:0016021 (14%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (14%);cytoplasm (7%);plasma membrane (5%),GO:0005524 (13%);GO:0003677 (10%);GO:0046872 (6%),ATP binding (13%);DNA binding (10%);metal ion binding (6%),GO:0006006 (4%);GO:0006355 (4%);GO:0032259 (2%),glucose metabolic process (4%);regulation of transcription, DNA-templated (4%);methylation (2%),IPR027417 (10%);IPR036291 (9%);IPR036388 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);NAD(P)-binding domain superfamily (9%);Winged helix-like DNA-binding domain superfamily (6%)
TEFAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (37%);6.1.1.19 (5%);5.2.1.8 (4%),Acting on polysaccharides (37%);Arginine--tRNA ligase (5%);Peptidylprolyl isomerase (4%),GO:0016021 (22%);GO:0005737 (9%);GO:0005887 (8%),integral component of membrane (22%);cytoplasm (9%);integral component of plasma membrane (8%),GO:0005524 (25%);GO:0016887 (8%);GO:0008932 (8%),ATP binding (25%);ATPase (8%);lytic endotransglycosylase activity (8%),GO:0009252 (8%);GO:0071555 (8%);GO:0055085 (4%),peptidoglycan biosynthetic process (8%);cell wall organization (8%);transmembrane transport (4%),IPR027417 (16%);IPR003593 (9%);IPR003798 (8%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (9%);DNA recombination RmuC (8%)
MCGDDAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMTQLVNHVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (64%);2.7.7.6 (14%);1.8.4.11 (7%),Glycine--tRNA ligase (64%);DNA-directed RNA polymerase (14%);Peptide-methionine (S)-S-oxide reductase (7%),GO:0005737 (41%);GO:0016021 (7%);GO:0000502 (4%),cytoplasm (41%);integral component of membrane (7%);proteasome complex (4%),GO:0003677 (41%);GO:0005524 (37%);GO:0004820 (33%),DNA binding (41%);ATP binding (37%);glycine-tRNA ligase activity (33%),GO:0006426 (33%);GO:0006351 (7%);GO:0009405 (7%),glycyl-tRNA aminoacylation (33%);transcription, DNA-templated (7%);obsolete pathogenesis (7%),IPR002315 (33%);IPR004154 (33%);IPR006195 (33%),Glycyl-tRNA synthetase (33%);Anticodon-binding (33%);Aminoacyl-tRNA synthetase, class II (33%)
NMCAVVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGDDNNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMSDYDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYMLPAQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VCMGAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEWGALYSSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ATQMVDLMCLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAMYLPAQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVEGNEQFLANAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AHQCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.- (19%);2.2.1.9 (13%);3.5.1.52 (13%),Carboxylic ester hydrolases (19%);2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic-acisynthase (13%);Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (13%),GO:0005739 (18%);GO:0005634 (15%);GO:0016021 (15%),mitochondrion (18%);nucleus (15%);integral component of membrane (15%),GO:0046872 (20%);GO:0003677 (15%);GO:0003700 (5%),metal ion binding (20%);DNA binding (15%);DNA-binding transcription factor activity (5%),GO:0006355 (19%);GO:0070131 (18%);GO:0006281 (6%),regulation of transcription, DNA-templated (19%);positive regulation of mitochondrial translation (18%);DNA repair (6%),IPR013087 (20%);IPR036236 (20%);IPR003734 (18%),Zinc finger C2H2-type (20%);Zinc finger C2H2 superfamily (20%);Domain of unknown function DUF155 (18%)
HTPAMQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLSAPDDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMTTSVQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMVLPAEGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYVMTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,GO:0055085 (100%),transmembrane transport (100%),IPR000515 (100%);IPR035906 (100%),ABC transporter type 1, transmembrane domain MetI-like (100%);MetI-like superfamily (100%)
QVLVAQPGQTTGTAEEFANR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFVASSVQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSGGGSSGGSLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (53%);GO:0001533 (44%),keratin filament (100%);plasma membrane (53%);cornified envelope (44%),GO:0046982 (47%);GO:0030246 (44%);GO:0030280 (44%),protein heterodimerization activity (47%);carbohydrate binding (44%);structural constituent of skin epidermis (44%),GO:0050728 (47%);GO:0051290 (47%);GO:0061436 (47%),negative regulation of inflammatory response (47%);protein heterotetramerization (47%);establishment of skin barrier (47%),IPR032449 (100%);IPR003054 (97%);IPR039008 (97%),Keratin type II cytoskeletal 1, tail (100%);Keratin, type II (97%);Intermediate filament, rod domain (97%)
GNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
VVTLVSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0008137 (100%);GO:0051539 (100%),NADH dehydrogenase (ubiquinone) activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0042773 (100%),ATP synthesis coupled electron transport (100%),IPR000283 (100%);IPR001041 (100%);IPR006656 (100%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (100%);2Fe-2S ferredoxin-type iron-sulfur binding domain (100%);Molybdopterin oxidoreductase (100%)
VFLSSLTK,Puniceicoccaceae,Bacteria,,,,Verrucomicrobia,,,Opitutae,,,Puniceicoccales,,,,Puniceicoccaceae,,,,,,,,,,,,,,,,GO:0043190 (100%),ATP-binding cassette (ABC) transporter complex (100%),,,GO:0055085 (100%),transmembrane transport (100%),IPR000914 (100%);IPR030678 (100%);IPR039424 (100%),Solute-binding protein family 5 domain (100%);Peptide/nickel binding protein, MppA-type (100%);Solute-binding protein family 5 (100%)
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLGLTAHLTTGQAG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVTVSPLR,Streptomyces,Bacteria,,,,Actinobacteria,,,Actinomycetia,,,Streptomycetales,,,,Streptomycetaceae,,,,Streptomyces,,,,,,,,,,,,,,GO:0016791 (100%),phosphatase activity (100%),,,IPR001932 (100%);IPR029016 (100%);IPR036457 (100%),PPM-type phosphatase domain (100%);GAF-like domain superfamily (100%);PPM-type phosphatase domain superfamily (100%)
QFLANAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.24 (70%);1.1.1.267 (20%);2.7.1.2 (10%),Phosphoribosylanthranilate isomerase (70%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (20%);Glucokinase (10%),GO:0005634 (17%);GO:0005737 (6%),nucleus (17%);cytoplasm (6%),GO:0004640 (39%);GO:0003677 (17%);GO:0016853 (11%),phosphoribosylanthranilate isomerase activity (39%);DNA binding (17%);isomerase activity (11%),GO:0000162 (39%);GO:0016114 (11%);GO:0019288 (11%),tryptophan biosynthetic process (39%);terpenoid biosynthetic process (11%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (11%),IPR001240 (33%);IPR011060 (33%);IPR013785 (33%),N-(5'phosphoribosyl) anthranilate isomerase (PRAI) domain (33%);Ribulose-phosphate binding barrel (33%);Aldolase-type TIM barrel (33%)
LVNELTEFAK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (88%);GO:0032991 (17%);GO:0005783 (13%),extracellular space (88%);protein-containing complex (17%);endoplasmic reticulum (13%),GO:0046872 (71%);GO:0003677 (17%);GO:0005504 (17%),metal ion binding (71%);DNA binding (17%);fatty acid binding (17%),GO:0009267 (17%);GO:0043066 (17%);GO:0051659 (17%),cellular response to starvation (17%);negative regulation of apoptotic process (17%);maintenance of mitochondrion location (17%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
TAHLVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.71 (100%),Shikimate kinase (100%),GO:0016021 (29%);GO:0005886 (21%);GO:0005737 (4%),integral component of membrane (29%);plasma membrane (21%);cytoplasm (4%),GO:0005524 (21%);GO:0003677 (17%);GO:0016887 (8%),ATP binding (21%);DNA binding (17%);ATPase (8%),GO:0042981 (29%);GO:0015833 (8%);GO:0019350 (8%),regulation of apoptotic process (29%);peptide transport (8%);teichoic acid biosynthetic process (8%),IPR027417 (54%);IPR001452 (39%);IPR001478 (39%),P-loop containing nucleoside triphosphate hydrolase (54%);SH3 domain (39%);PDZ domain (39%)
AVLHEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.104 (74%);3.6.4.12 (4%);6.1.1.3 (3%),Cyanase (74%);DNA helicase (4%);Threonine--tRNA ligase (3%),GO:0016021 (13%);GO:0005737 (7%);GO:0005815 (4%),integral component of membrane (13%);cytoplasm (7%);microtubule organizing center (4%),GO:0003677 (51%);GO:0008824 (48%);GO:0005524 (11%),DNA binding (51%);cyanate hydratase activity (48%);ATP binding (11%),GO:0009439 (48%);GO:0007165 (4%);GO:0006355 (3%),cyanate metabolic process (48%);signal transduction (4%);regulation of transcription, DNA-templated (3%),IPR003712 (44%);IPR036581 (44%);IPR008076 (43%),Cyanate lyase, C-terminal (44%);Cyanate lyase, C-terminal domain superfamily (44%);Cyanate hydratase (43%)
GDLVPGTGTVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (97%);2.3.1.20 (1%);2.3.3.14 (1%),3-methyl-2-oxobutanoate hydroxymethyltransferase (97%);Diacylglycerol O-acyltransferase (1%);Homocitrate synthase (1%),GO:0005737 (74%);GO:0016021 (2%);GO:0005886 (1%),cytoplasm (74%);integral component of membrane (2%);plasma membrane (1%),GO:0046872 (86%);GO:0003864 (74%);GO:0008168 (72%),metal ion binding (86%);3-methyl-2-oxobutanoate hydroxymethyltransferase activity (74%);methyltransferase activity (72%),GO:0015940 (74%);GO:0032259 (72%);GO:0045892 (4%),pantothenate biosynthetic process (74%);methylation (72%);negative regulation of transcription, DNA-templated (4%),IPR003700 (73%);IPR015813 (73%);IPR040442 (73%),Ketopantoate hydroxymethyltransferase (73%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (73%);Pyruvate kinase-like domain superfamily (73%)
WLQQTLAAN,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,,,GO:0005615 (8%),extracellular space (8%),GO:0004252 (100%),serine-type endopeptidase activity (100%),GO:0006508 (8%),proteolysis (8%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LGEHNLDVLE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPLAGSAFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVPAPLLGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGPVTVPR,Streptomyces,Bacteria,,,,Actinobacteria,,,Actinomycetia,,,Streptomycetales,,,,Streptomycetaceae,,,,Streptomyces,,,,,,,,,,,,,,,,,,IPR036291 (100%),NAD(P)-binding domain superfamily (100%)
CAGQLASK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLNAGLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVDFTNAFAQGTLSELVYL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (13%);6.1.1.20 (12%);5.3.1.23 (10%),Histidine kinase (13%);Phenylalanine--tRNA ligase (12%);S-methyl-5-thioribose-1-phosphate isomerase (10%),GO:0016021 (32%);GO:0005737 (9%);GO:0005886 (6%),integral component of membrane (32%);cytoplasm (9%);plasma membrane (6%),GO:0005524 (13%);GO:0046872 (9%);GO:0003677 (6%),ATP binding (13%);metal ion binding (9%);DNA binding (6%),GO:0006432 (3%);GO:0019284 (2%);GO:0019509 (2%),phenylalanyl-tRNA aminoacylation (3%);L-methionine salvage from S-adenosylmethionine (2%);L-methionine salvage from methylthioadenosine (2%),IPR027417 (8%);IPR007300 (6%);IPR036890 (4%),P-loop containing nucleoside triphosphate hydrolase (8%);CidB/LrgB family (6%);Histidine kinase/HSP90-like ATPase superfamily (4%)
GAPALGVAGA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHGGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.8 (29%);3.6.4.12 (17%);6.3.4.3 (14%),Polyribonucleotide nucleotidyltransferase (29%);DNA helicase (17%);Formate--tetrahydrofolate ligase (14%),GO:0016021 (25%);GO:0005737 (14%);GO:1990077 (8%),integral component of membrane (25%);cytoplasm (14%);primosome complex (8%),GO:0005524 (24%);GO:0003723 (14%);GO:0004654 (13%),ATP binding (24%);RNA binding (14%);polyribonucleotide nucleotidyltransferase activity (13%),GO:0006402 (13%);GO:0006396 (10%);GO:0034765 (9%),mRNA catabolic process (13%);RNA processing (10%);regulation of ion transmembrane transport (9%),IPR027417 (19%);IPR003029 (13%);IPR022967 (12%),P-loop containing nucleoside triphosphate hydrolase (19%);S1 domain (13%);RNA-binding domain, S1 (12%)
HVAGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.21 (22%);2.4.1.129 (14%);3.4.16.4 (12%),Nicotinate phosphoribosyltransferase (22%);Peptidoglycan glycosyltransferase (14%);Serine-type D-Ala-D-Ala carboxypeptidase (12%),GO:0005840 (19%);GO:0016021 (12%);GO:0005737 (4%),ribosome (19%);integral component of membrane (12%);cytoplasm (4%),GO:0016787 (28%);GO:0003735 (19%);GO:0046872 (6%),hydrolase activity (28%);structural constituent of ribosome (19%);metal ion binding (6%),GO:0005975 (30%);GO:0006412 (19%);GO:0045892 (2%),carbohydrate metabolic process (30%);translation (19%);negative regulation of transcription, DNA-templated (2%),IPR012878 (29%);IPR008928 (28%);IPR000630 (18%),Beta-L-arabinofuranosidase, GH127 (29%);Six-hairpin glycosidase superfamily (28%);Ribosomal protein S8 (18%)
APVPLSVLC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GALLVLTFDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSMEALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (67%);5.3.1.29 (33%),Histidine kinase (67%);Ribose 1,5-bisphosphate isomerase (33%),GO:0016021 (82%),integral component of membrane (82%),GO:0005524 (73%);GO:0016887 (73%);GO:0042626 (73%),ATP binding (73%);ATPase (73%);ATPase-coupled transmembrane transporter activity (73%),GO:0019323 (9%);GO:0044249 (9%),pentose catabolic process (9%);cellular biosynthetic process (9%),IPR003439 (73%);IPR003593 (73%);IPR011527 (73%),ABC transporter-like (73%);AAA+ ATPase domain (73%);ABC transporter type 1, transmembrane domain (73%)
VVPETAPLLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PLVLMLQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LALTAVHNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SCLLS,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.- (22%);3.2.1.18 (22%);3.6.5.2 (22%),Pentosyltransferases (22%);Exo-alpha-sialidase (22%);Small monomeric GTPase (22%),GO:0016020 (14%);GO:0016021 (12%);GO:0005856 (9%),membrane (14%);integral component of membrane (12%);cytoskeleton (9%),GO:0003924 (28%);GO:0005525 (28%);GO:0003950 (21%),GTPase activity (28%);GTP binding (28%);NAD+ ADP-ribosyltransferase activity (21%),GO:0007165 (16%);GO:0030837 (9%);GO:0007264 (5%),signal transduction (16%);negative regulation of actin filament polymerization (9%);small GTPase mediated signal transduction (5%),IPR027417 (27%);IPR001806 (25%);IPR005225 (21%),P-loop containing nucleoside triphosphate hydrolase (27%);Small GTPase (25%);Small GTP-binding protein domain (21%)
LGEHNLDVLEGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLASPDDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MNVPKPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.4 (8%);2.7.11.1 (6%);2.7.10.1 (5%),Ribonuclease H (8%);Non-specific serine/threonine protein kinase (6%);Receptor protein-tyrosine kinase (5%),GO:0031461 (23%);GO:0016021 (18%);GO:0005737 (4%),cullin-RING ubiquitin ligase complex (23%);integral component of membrane (18%);cytoplasm (4%),GO:0031625 (28%);GO:0005524 (24%);GO:0003677 (8%),ubiquitin protein ligase binding (28%);ATP binding (24%);DNA binding (8%),GO:0006511 (27%);GO:0016567 (17%);GO:0006281 (2%),ubiquitin-dependent protein catabolic process (27%);protein ubiquitination (17%);DNA repair (2%),IPR001373 (26%);IPR036317 (26%);IPR016158 (25%),Cullin, N-terminal (26%);Cullin homology domain superfamily (26%);Cullin homology domain (25%)
VVVTLSPR,Hypsibius dujardini,Eukaryota,Metazoa,,,Tardigrada,,,Eutardigrada,,,Parachela,,,Hypsibioidea,Hypsibiidae,,,,Hypsibius,,,,Hypsibius dujardini,,,,,,,,,,GO:0005524 (100%);GO:0016887 (100%),ATP binding (100%);ATPase (100%),,,IPR003593 (100%);IPR003959 (100%);IPR027417 (100%),AAA+ ATPase domain (100%);ATPase, AAA-type, core (100%);P-loop containing nucleoside triphosphate hydrolase (100%)
VVGPLPLPTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (99%);GO:0009507 (3%);GO:0005737 (1%),ribosome (99%);chloroplast (3%);cytoplasm (1%),GO:0003735 (98%);GO:0000049 (93%);GO:0003723 (4%),structural constituent of ribosome (98%);tRNA binding (93%);RNA binding (4%),GO:0006412 (99%),translation (99%),IPR001848 (100%);IPR027486 (100%);IPR036838 (100%),Ribosomal protein S10 (100%);Ribosomal protein S10 domain (100%);Ribosomal protein S10 domain superfamily (100%)
EQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAPLVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.13 (44%);6.3.2.- (17%);1.-.-.- (6%),Phosphoribosylamine--glycine ligase (44%);Acid--amino-acid ligases (peptide synthases) (17%);Oxidoreductases (6%),GO:0016021 (41%);GO:0005840 (3%);GO:0031207 (3%),integral component of membrane (41%);ribosome (3%);Sec62/Sec63 complex (3%),GO:0005524 (62%);GO:0016887 (34%);GO:0042626 (30%),ATP binding (62%);ATPase (34%);ATPase-coupled transmembrane transporter activity (30%),GO:0006189 (13%);GO:0009113 (13%);GO:0005975 (5%),'de novo' IMP biosynthetic process (13%);purine nucleobase biosynthetic process (13%);carbohydrate metabolic process (5%),IPR027417 (35%);IPR003439 (34%);IPR003593 (32%),P-loop containing nucleoside triphosphate hydrolase (35%);ABC transporter-like (34%);AAA+ ATPase domain (32%)
SLSLSLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (78%);3.6.4.12 (11%);5.6.2.1 (11%),DNA-directed DNA polymerase (78%);DNA helicase (11%);DNA topoisomerase (11%),GO:0005680 (29%);GO:0005634 (14%);GO:0005576 (5%),anaphase-promoting complex (29%);nucleus (14%);extracellular region (5%),GO:0003887 (33%);GO:0003677 (10%);GO:0003700 (10%),DNA-directed DNA polymerase activity (33%);DNA binding (10%);DNA-binding transcription factor activity (10%),GO:0007049 (29%);GO:0051301 (29%);GO:0000002 (5%),cell cycle (29%);cell division (29%);mitochondrial genome maintenance (5%),IPR027417 (41%);IPR024990 (27%);IPR041221 (18%),P-loop containing nucleoside triphosphate hydrolase (41%);Anaphase-promoting complex subunit 1 (27%);Anaphase-promoting complex subunit 1, C-terminal (18%)
APDLVELLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLPLTSTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (50%);GO:0005524 (50%);GO:0016887 (50%),nucleic acid binding (50%);ATP binding (50%);ATPase (50%),GO:0015833 (50%),peptide transport (50%),IPR003439 (33%);IPR003593 (33%);IPR012337 (33%),ABC transporter-like (33%);AAA+ ATPase domain (33%);Ribonuclease H-like superfamily (33%)
EFLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.40 (12%);2.7.7.7 (5%);6.1.1.5 (4%),Pyruvate kinase (12%);DNA-directed DNA polymerase (5%);Isoleucine--tRNA ligase (4%),GO:0016021 (18%);GO:0005737 (9%);GO:0005886 (5%),integral component of membrane (18%);cytoplasm (9%);plasma membrane (5%),GO:0005524 (31%);GO:0016887 (11%);GO:0015424 (9%),ATP binding (31%);ATPase (11%);ABC-type amino acid transporter activity (9%),GO:0015074 (1%);GO:0032259 (1%);GO:0006412 (1%),DNA integration (1%);methylation (1%);translation (1%),IPR027417 (18%);IPR003593 (10%);IPR003439 (8%),P-loop containing nucleoside triphosphate hydrolase (18%);AAA+ ATPase domain (10%);ABC transporter-like (8%)
LAVLVDLGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (33%),integral component of membrane (33%),GO:0003677 (67%);GO:0008170 (67%);GO:0000155 (33%),DNA binding (67%);N-methyltransferase activity (67%);phosphorelay sensor kinase activity (33%),GO:0006306 (67%),DNA methylation (67%),IPR002295 (50%);IPR002941 (50%);IPR003018 (50%),N6 adenine-specific DNA methyltransferase, D21 class (50%);DNA methylase N-4/N-6 (50%);GAF domain (50%)
AGAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.- (10%);6.1.1.5 (6%);3.4.21.- (5%),Acting on amino acids and derivatives (10%);Isoleucine--tRNA ligase (6%);Serine endopeptidases (5%),GO:0016021 (15%);GO:0005737 (7%);GO:0005634 (3%),integral component of membrane (15%);cytoplasm (7%);nucleus (3%),GO:0046872 (26%);GO:0004022 (20%);GO:0008774 (19%),metal ion binding (26%);alcohol dehydrogenase (NAD+) activity (20%);acetaldehyde dehydrogenase (acetylating) activity (19%),GO:0015976 (19%);GO:0006066 (19%);GO:0006814 (2%),carbon utilization (19%);alcohol metabolic process (19%);sodium ion transport (2%),IPR016161 (21%);IPR015590 (21%);IPR016162 (21%),Aldehyde/histidinol dehydrogenase (21%);Aldehyde dehydrogenase domain (21%);Aldehyde dehydrogenase, N-terminal (21%)
LHVVSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%);GO:0005737 (8%);GO:0005874 (8%),integral component of membrane (25%);cytoplasm (8%);microtubule (8%),GO:0004497 (25%);GO:0005506 (25%);GO:0016705 (25%),monooxygenase activity (25%);iron ion binding (25%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (25%),GO:0006535 (17%);GO:0070527 (17%);GO:0007018 (8%),cysteine biosynthetic process from serine (17%);platelet aggregation (17%);microtubule-based movement (8%),IPR008979 (36%);IPR000421 (29%);IPR000859 (29%),Galactose-binding-like domain superfamily (36%);Coagulation factor 5/8 C-terminal domain (29%);CUB domain (29%)
LPGFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (14%);4.3.2.9 (8%);4.3.2.7 (6%),DNA topoisomerase (ATP-hydrolyzing) (14%);Gamma-glutamylcyclotransferase (8%);Glutathione-specific gamma-glutamylcyclotransferase (6%),GO:0016021 (40%);GO:0005886 (9%);GO:0005737 (4%),integral component of membrane (40%);plasma membrane (9%);cytoplasm (4%),GO:0003677 (8%);GO:0046872 (8%);GO:0005524 (7%),DNA binding (8%);metal ion binding (8%);ATP binding (7%),GO:0017000 (5%);GO:0006265 (4%);GO:0006751 (3%),antibiotic biosynthetic process (5%);DNA topological change (4%);glutathione catabolic process (3%),IPR007632 (17%);IPR015421 (7%);IPR015424 (7%),Anoctamin (17%);Pyridoxal phosphate-dependent transferase, major domain (7%);Pyridoxal phosphate-dependent transferase (7%)
EADVVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.6.1.16 (100%),tRNA-intron lyase (100%),GO:0005737 (55%);GO:0016021 (36%);GO:0005886 (27%),cytoplasm (55%);integral component of membrane (36%);plasma membrane (27%),GO:0000213 (9%);GO:0003676 (9%);GO:0016829 (9%),tRNA-intron endonuclease activity (9%);nucleic acid binding (9%);lyase activity (9%),GO:0006388 (9%),tRNA splicing, via endonucleolytic cleavage and ligation (9%),IPR013087 (38%);IPR029044 (38%);IPR041175 (38%),Zinc finger C2H2-type (38%);Nucleotide-diphospho-sugar transferases (38%);VLRF1/Vms1 (38%)
TLTLSLDLR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,3.4.16.4 (100%),Serine-type D-Ala-D-Ala carboxypeptidase (100%),GO:0005887 (100%),integral component of plasma membrane (100%),GO:0009002 (100%);GO:0008658 (80%);GO:0008955 (80%),serine-type D-Ala-D-Ala carboxypeptidase activity (100%);penicillin binding (80%);peptidoglycan glycosyltransferase activity (80%),GO:0009252 (100%);GO:0043093 (100%);GO:0000917 (80%),peptidoglycan biosynthetic process (100%);FtsZ-dependent cytokinesis (100%);division septum assembly (80%),IPR001460 (100%);IPR005311 (100%);IPR012338 (100%),Penicillin-binding protein, transpeptidase (100%);Penicillin-binding protein, dimerisation domain (100%);Beta-lactamase/transpeptidase-like (100%)